BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23486712)

  • 1. Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis.
    White PL; Parr C; Thornton C; Barnes RA
    J Clin Microbiol; 2013 May; 51(5):1510-6. PubMed ID: 23486712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology.
    Thornton C; Johnson G; Agrawal S
    J Vis Exp; 2012 Mar; (61):. PubMed ID: 22473419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing Invasive Pulmonary Aspergillosis in Hematology Patients: a Retrospective Multicenter Evaluation of a Novel Lateral Flow Device.
    Mercier T; Schauwvlieghe A; de Kort E; Dunbar A; Reynders M; Guldentops E; Rijnders B; Verweij PE; Lagrou K; Maertens J
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30651395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
    J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a Novel
    Dichtl K; Seybold U; Ormanns S; Horns H; Wagener J
    J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31018980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
    Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
    Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Biomarker Screening for Diagnosis of Invasive Aspergillosis in High-Risk Pediatric Patients.
    Loeffler J; Hafner J; Mengoli C; Wirth C; Heussel CP; Löffler C; White PL; Ullmann AJ; Michel D; Wiegering V; Wölfl M; Schlegel PG; Einsele H; Springer J; Eyrich M
    J Clin Microbiol; 2017 Jan; 55(1):101-109. PubMed ID: 27795339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the JF5-Based Galactomannoprotein EIA Compared to the Lateral Flow Device and the Galactomannan EIA in Serum and Bronchoalveolar Lavage Fluid.
    Aerts R; Mercier T; Houben E; Schauwvlieghe A; Lagrou K; Maertens J
    J Clin Microbiol; 2022 Nov; 60(11):e0094822. PubMed ID: 36214562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: A single-centre study.
    Serin I; Dogu MH
    Mycoses; 2021 Jun; 64(6):678-683. PubMed ID: 33683715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis.
    Scotter JM; Campbell P; Anderson TP; Murdoch DR; Chambers ST; Patton WN
    Pathology; 2005 Jun; 37(3):246-53. PubMed ID: 16175901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients.
    Castillo CG; Kauffman CA; Zhai J; Jiang H; Agozino SM; Miceli MH
    Mycoses; 2018 Jan; 61(1):4-10. PubMed ID: 28905439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples.
    Danylo A; Courtemanche C; Pelletier R; Boudreault AA
    Med Mycol; 2014 Aug; 52(6):577-83. PubMed ID: 25023484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The performance of galactomannan in combination with 1,3-β-D-glucan or aspergillus-lateral flow device for the diagnosis of invasive aspergillosis: Evidences from 13 studies.
    Zhang L; Guo Z; Xie S; Zhou J; Chen G; Feng J; Huang Y
    Diagn Microbiol Infect Dis; 2019 Jan; 93(1):44-53. PubMed ID: 30279025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk hematological patients.
    Springer J; Morton CO; Perry M; Heinz WJ; Paholcsek M; Alzheimer M; Rogers TR; Barnes RA; Einsele H; Loeffler J; White PL
    J Clin Microbiol; 2013 May; 51(5):1445-50. PubMed ID: 23426930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
    Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
    Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
    Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
    Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of clinical characteristics on the performance of galactomannan and PCR for the diagnosis of invasive aspergillosis in febrile neutropenic patients.
    Oz Y; Aslan M; Aksit F; Metintas S; Gunduz E
    Mycoses; 2016 Feb; 59(2):86-92. PubMed ID: 26627843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.
    Aguado JM; Vázquez L; Fernández-Ruiz M; Villaescusa T; Ruiz-Camps I; Barba P; Silva JT; Batlle M; Solano C; Gallardo D; Heras I; Polo M; Varela R; Vallejo C; Olave T; López-Jiménez J; Rovira M; Parody R; Cuenca-Estrella M; ; ; ;
    Clin Infect Dis; 2015 Feb; 60(3):405-14. PubMed ID: 25336623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a novel lateral-flow device to galactomannan assay at different time periods for detections of invasive aspergillosis.
    Hsiao HH; Liu YC; Wang HC; Du JS; Tang SH; Yeh TJ; Hsieh CY; Gau YC; Ke YL; Chuang TM; Hsiao CE; Yen CH; Cho SF; Hsiao SY; Chiou SS; Lin SY; Hsu CM; Lu PL
    J Formos Med Assoc; 2022 Oct; 121(10):2123-2129. PubMed ID: 35570052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.